Log in

NASDAQ:CVETCovetrus Insider Trades

$17.88
+0.66 (+3.83 %)
(As of 07/3/2020 04:00 PM ET)
Add
Compare
Today's Range
$17.11
Now: $17.88
$17.98
50-Day Range
$11.21
MA: $16.31
$18.87
52-Week Range
$4.05
Now: $17.88
$25.89
Volume1.32 million shs
Average Volume1.74 million shs
Market Capitalization$2.00 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.75

Insider Trades

Covetrus (NASDAQ:CVET) Insider Buying and Selling Activity

Insider Ownership Percentage: 3.90%

Insider Buying and Selling by Quarter


Covetrus (NASDAQ CVET) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/21/2020Edward McnamaraDirectorSell20,000$15.03$300,600.0041,792  
8/21/2019Benjamin ShawCEOBuy1,800$13.87$24,966.00  
8/21/2019Erin Powers BrennanInsiderBuy1,684$14.90$25,091.60  
5/21/2019David Christopher DollarInsiderSell685$28.33$19,406.05  
5/17/2019Betsy S AtkinsDirectorSell150,845$27.80$4,193,491.00  
5/17/2019Timothy LudlowInsiderSell81,498$28.01$2,282,758.98  
(Data available from 1/1/2013 forward)
This page was last updated on 7/4/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.